Alban Canali

22PUBLICATIONS
36CO-AUTHORS
Tumour immunologyImmunogenetics (incl. genetic immunology)Haematological tumoursMedical mycologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 09, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia.

Laetitia Largeaud, Charlotte Syrykh, Julie Vial

|May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.

Camille Gondran, Pierre-Yves Dumas, Emilie Bérard

|Apr 04, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.

Charles Dussiau, Thibault Comont, Camille Knosp

|Feb 24, 2024
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.

Mathias Chea, Lucie Rigolot, Alban Canali

|Aug 04, 2023
Use of a hybrid intelligence decision tree to identify mature B-cell neoplasms.

Inès Vergnolle, Theo Ceccomarini, Alban Canali

|Nov 01, 2022
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.

Alban Canali, Inès Vergnolle, Sarah Bertoli

Pageof 4

Frequent Collaborators

14 joint publications

Jean-Baptiste Rieu

7 joint publications

François Vergez

5 joint publications

Barbara J Bain

5 joint publications

Sarah Bertoli